We are live on ! Find out more
NVCR icon

NovoCure
NVCR

238 hedge funds and large institutions have $1.24B invested in NovoCure in 2025 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 100 increasing their positions, 61 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

191% more call options, than puts

Call options by funds: $16.7M | Put options by funds: $5.74M

64% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 61

10% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 40

3.34% more ownership

Funds ownership: 82.04% → 85.38% (+3.3%)

4% more capital invested

Capital invested by funds: $1.19B → $1.24B (+$50.9M)

2% less funds holding

Funds holding: 244 → 238 (-6)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
238
Holders Change
-6
Holders Change %
-2.46%
% of All Funds
2.89%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
44
Increased
100
Reduced
61
Closed
40
Calls
$16.7M
Puts
$5.74M
Net Calls
+$11M
Net Calls Change
-$5M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$53.3M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$14.4M
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$11.9M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$10.1M
5
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$7.38M

Top Sellers

1
Capital World Investors
Capital World Investors
California
-$25.8M
2
SCM
Soleus Capital Management
Connecticut
-$14.3M
3
Marshall Wace
Marshall Wace
United Kingdom
-$13.4M
4
UBS AM
UBS AM
Illinois
-$12.4M
5
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$12.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
RIL
201
Rothschild Investment LLC
Illinois
$2.87K +$1.37K +107 +93%
EWP
202
Elevation Wealth Partners
California
$2.81K +$706 +55 +34%
GWM
203
Geneos Wealth Management
Colorado
$2.75K – – –
AA
204
Addison Advisors
Vermont
$2.59K – – –
WSFS
205
Wilmington Savings Fund Society
Delaware
$2.59K – – –
PWPS
206
Pinnacle Wealth Planning Services
Ohio
$1.72K +$1.71K +133 New
PA
207
Parallel Advisors
California
$1.67K -$3.8K -296 -70%
CIBC Private Wealth Group
208
CIBC Private Wealth Group
Georgia
$1.6K – – –
SPIA
209
Steward Partners Investment Advisory
New York
$1.54K -$13 -1 -0.8%
ATC
210
Adirondack Trust Company
New York
$1.29K – – –
TCM
211
Triumph Capital Management
Colorado
$1.29K +$1.28K +100 New
PFBT
212
Parkside Financial Bank & Trust
Missouri
$1.22K -$1.33K -104 -53%
FHA
213
Flagship Harbor Advisors
Massachusetts
$1.1K +$1.09K +85 New
HBW
214
Hazlett, Burt & Watson
West Virginia
$1K – – –
RFP
215
Root Financial Partners
California
$789 +$783 +61 New
MCM
216
MAI Capital Management
Ohio
$750 +$205 +16 +38%
TM
217
Torren Management
California
$750 +$745 +58 New
AWM
218
Abound Wealth Management
Tennessee
$699 – – –
National Bank of Canada
219
National Bank of Canada
Quebec, Canada
$672 -$2.88K -224 -81%
MPWT
220
MassMutual Private Wealth & Trust
Connecticut
$659 -$1.21K -94 -65%
TF
221
Tompkins Financial
New York
$647 – – –
MCM
222
Manchester Capital Management
Vermont
$479 +$475 +37 New
BFS
223
Bare Financial Services
Pennsylvania
$478 +$475 +37 New
Los Angeles Capital Management
224
Los Angeles Capital Management
California
$449 +$449 +35 New
CIAM
225
Caitong International Asset Management
Hong Kong
$401 +$398 +31 New
7 8
9
10 11

NVCR Hedge Fund Activity: Q4 2025 in Review

238 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q4 2025, worth a combined $1.24B — up 4.3% from $1.19B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new NVCR positions and 40 closed out — a net gain of 4 holders — while 100 added to existing stakes and 61 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $53.3M. The largest seller was Capital World Investors, exiting entirely with an estimated $25.8M sold.

  • 238 institutional investors held NovoCure (NVCR) as of Q4 2025, down from 244 in Q3 2025.
  • Funds reported $1.24B of NovoCure stock for Q4 2025, up 4.3% quarter-over-quarter.
  • 44 funds opened new NovoCure positions in Q4 2025 and 40 closed out, a net change of +4 holders.
  • The largest NovoCure buyer in Q4 2025 was Morgan Stanley, an estimated $53.3M added.
  • The largest NovoCure seller in Q4 2025 was Capital World Investors, an estimated $25.8M sold.

Based on aggregated 13F filings for Q4 2025.